|
|
||||||||
J Thorac Cardiovasc Surg 1998;115:671-680
© 1998 Mosby, Inc.
GENERAL THORACIC SURGERY |

From The Thoracic Service, Department of Surgerya and the Pathology Department,b Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Received for publication March 17, 1997; revisions requested July 15, 1997; revisions received Sept. 26, 1997; accepted for publication Sept. 29, 1997. Address for reprints: Robert J. Ginsberg, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
Primary sarcomas of the mediastinum are rare, and data concerning treatment and results of therapy are sparse.
Objective: To assess presentation, management, prognostic factors, and survival in mediastinal sarcomas.
Methods: We reviewed our experience with 47 patients with the diagnosis of primary sarcoma of the mediastinum. Data were collected from a computerized institutional database and medical records. Survival was analyzed by Kaplan-Meier method and comparisons of survival by log rank test.
Results: The median age of 47 patients with mediastinal sarcoma was 39 years (range 2.5 to 69 years), with a male/female ratio of 1.6. The most common complaints were chest/shoulder pain (38%) and dyspnea (23%). The most common tumor types were malignant peripheral nerve tumor (26%), spindle cell sarcoma (15%), leiomyosarcoma (9%), and liposarcoma (9%). Operation was the primary treatment modality in 72% of cases (n = 34); 22 sarcomas (47%) were completely resected. The overall 5-year survival was 32%. High-grade lesions had a significantly decreased survival (5-year survival = 27%) compared with low-grade tumors (5-year survival = 66%) (p = 0.05). The overwhelming factor determining survival was the ability to completely resect the tumors (5-year survival 49% for complete resection; 3-year survival 18% for incomplete or no resection) (p = 0.0016). Despite complete resection, local recurrence occurred in 64% of cases.
Conclusion: Because the overall survival for patients with mediastinal sarcomas is 32% and the local recurrence is 64% for tumors completely resected, aggressive adjuvant therapy should continue to be systematically explored.
This article has been cited by other articles:
![]() |
M. D'Aiuto, G. Veronesi, G. Pompilio, R. Gasparri, F. Presicci, D. Galetta, P. Biglioli, and L. Spaggiari Extended right pneumonectomy with partial left atrial resection for primary leiomyosarcoma of the mediastinum J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 694 - 695. [Full Text] [PDF] |
||||
![]() |
Y. Ohta, T. Murata, M. Tamura, H. Sato, H. Kurumaya, and K. Katayanagi Surgical resection of recurrent bilateral mediastinal liposarcoma through the clamshell approach Ann. Thorac. Surg., May 1, 2004; 77(5): 1837 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eroglu, C. Kurkcuoglu, N. Karaoglanoglu, and N. Gursan Primary leiomyosarcoma of the anterior mediastinum Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 943 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kara, M. Ozkan, S. Dizbay Sak, and S. Kavukcu Successful removal of a giant recurrent mediastinal liposarcoma involving both hemithoraces Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 647 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aubert, P. Chaffanjon, M. Peoc'h, and P. Y. Brichon Chest wall implantation of a mediastinal liposarcoma after thoracoscopy Ann. Thorac. Surg., May 1, 2000; 69(5): 1579 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Morse, E. Bossen, T. A. D'Amico, W. Williamson, and R. Johnson Myxoid Liposarcoma of the Supraclavicular Fossa Chest, May 1, 2000; 117(5): 1518 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Urschel and D. M Urschel Mediastinal fatty tumour Postgrad. Med. J., December 1, 1999; 75(890): 763 - 764. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |